Tournay, C.

patient cmv disease disease 2-nlvspecific cmv antigenemia donor cmv-seropositive cmv-specific recipient graft figure antigenemia number blood t-cell lymphocytes hla-a cytomegaloviru cmv infection infection t cells cmv-seronegative 2-nlv tetramer cmv-specific t cells response marrow pp 65 leukocytes cd 8 lymphocytes recovery sct recipients cmv-seropositive sct recipients peptide cmv-seropositive recipients protein 0.1 table treatment cmv-seropositive patients transplant study gcv treatment result detection ganciclovir sample allogeneic sheep erythrocyte rosetting range 9 cmv-seronegative patients group course sct donor gcv therapy al 15 figure 4 figure 3 cell transplantation cytotoxic transplantation t-celldepleted sct cell transplant 12 months bone marrow therapy 2-nlv tetramer month cmv-seronegative donor 4 patients correlation seropositive leukemia leukocyte assay binding 0.2 count volume repopulation t-celldepleted